You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Johnson and Johnson
Express Scripts
Baxter
Boehringer Ingelheim

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

TYLENOL W/ CODEINE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for TYLENOL W/ CODEINE
Drug patent expirations by year for TYLENOL W/ CODEINE
Recent Clinical Trials for TYLENOL W/ CODEINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of South FloridaN/A
Mahidol UniversityPhase 2
Children's Hospital of Michigan FoundationN/A

See all TYLENOL W/ CODEINE clinical trials

US Patents and Regulatory Information for TYLENOL W/ CODEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate SOLUTION;ORAL 085057-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Janssen Pharms TYLENOL W/ CODEINE NO. 2 acetaminophen; codeine phosphate TABLET;ORAL 085055-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate TABLET;ORAL 085056-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ortho Mcneil Pharm TYLENOL W/ CODEINE NO. 3 acetaminophen; codeine phosphate CAPSULE;ORAL 087422-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate TABLET;ORAL 085056-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ortho Mcneil Pharm TYLENOL W/ CODEINE acetaminophen; codeine phosphate TABLET;ORAL 085056-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Janssen Pharms TYLENOL W/ CODEINE NO. 1 acetaminophen; codeine phosphate TABLET;ORAL 085055-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Johnson and Johnson
Express Scripts
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.